ReviewThe Lancet. Haematology2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Abstract readReview
In one paragraph
Review in The Lancet. Haematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 4 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- A qualitative evidence synthesis on perinatal screening for sickle cell disease in high-burden countries.BMC global and public health · 2026Pooled it
- Burden and outcomes of cardiovascular and pulmonary complications in adolescents and adults with sickle cell disease: a systematic review and meta-analysis.Systematic reviews · 2026Pooled it
- Use of hydroxyurea in French-speaking Sub-Saharan Africa.Annals of hematology · 2025Guideline
- Genetic Polymorphisms Associated with Fetal Hemoglobin (HbF) Levels and F-Cell Numbers: A Systematic Review of Genome-Wide Association Studies.International journal of molecular sciences · 2024Pooled it
- Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks.Pediatric blood & cancer · 2025Trial
- Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial.Blood advances · 2025Trial
- India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.The Lancet regional health. Southeast Asia · 2026Article
- Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell Disease.European journal of haematology · 2026Observational
- EHA Guidelines on the management of children and adults with hemoglobin SC disease.HemaSphere · 2026Article
- Human erythroid models of sickle cell disease.HemaSphere · 2026Review
- Process-related determinants of quality of care for individuals with sickle cell disease in a tertiary facility in Ghana.BMJ open · 2026Article
- Regional brain iron deposition and functional alterations in thalassemia: a multimodal human study with murine validation.Annals of hematology · 2026Article
- Hydroxyurea for Ugandan Children with Sickle Cell Anemia.The New England journal of medicine · 2026Article
- Discordance Between Clinical Suspicion and Spirometry-Defined Reversible Airflow Obstruction in Children with Sickle Cell Disease in French Guiana.Journal of clinical medicine · 2026Article
- Asthma and overt stroke in children with sickle cell disease: a multicenter pediatric cohort study in French Guiana.BMC pediatrics · 2026Observational
- Preliminary Benefits of In-Home Virtual Reality for Chronic Pain in Sickle Cell Disease: Pilot Randomized Trial.Biomedicines · 2026Article
- Empirical estimate for the indirect healthcare costs of sickle cell disease from a retrospective cohort study in England between 2007 and 2019.BMC health services research · 2026Article
- EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies.HemaSphere · 2026Article
- Hematopoietic Cell Transplantation for Sickle Cell Disease.Children (Basel, Switzerland) · 2026Review
- The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care.Cells · 2026Review
34 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
33 authors.
Frédéric B PielDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. Electronic address: f.piel@imperial.ac.uk.
David C ReesDepartment of Paediatric Haematology, King's College London, King's College Hospital, London, UK.
Michael R DeBaunDepartment of Pediatrics, Vanderbilt-Meharry Center of Excellence for Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
Obiageli NnoduDepartment of Haematology and Blood Transfusion, College of Health Sciences and Centre of Excellence for Sickle Cell Disease Research and Training, University of Abuja, Abuja, Nigeria.
Brigitte RanqueDepartment of Internal Medicine, Georges Pompidou European Hospital, Assistance Publique-Hopitaux de Paris Centre, University of Paris Cité, Paris, France.
Alexis A ThompsonDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Russell E WareDivision of Hematology and Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Miguel R AbboudDepartment of Pediatrics and Adolescent Medicine, and Sickle Cell Program, American University of Beirut, Beirut, Lebanon.
Allistair AbrahamDivision of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA.
Emmanuela E AmbroseDepartment of Paediatrics and Child Health, Bugando Medical Centre, Mwanza, Tanzania.
Biree AndemariamNew England Sickle Cell Institute, University of Connecticut Health, Connecticut, USA.
Roshan ColahDepartment of Haematogenetics, Indian Council of Medical Research National Institute of Immunohaematology, Mumbai, India.
Raffaella ColombattiPediatric Oncology Hematology Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy.
Nicola ConranDepartment of Clinical Medicine, School of Medical Sciences, Center of Hematology and Hemotherapy (Hemocentro), University of Campinas-UNICAMP, Campinas, Brazil.
Fernando F CostaDepartment of Clinical Medicine, School of Medical Sciences, Center of Hematology and Hemotherapy (Hemocentro), University of Campinas-UNICAMP, Campinas, Brazil.
Robert M CroninDepartment of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Mariane de MontalembertDepartment of Pediatrics, Necker-Enfants Malades Hospital, Assistance Publique-Hopitaux de Paris Centre, Paris, France.
Jacques ElionParis Cité University and University of the Antilles, Inserm, BIGR, Paris, France.
Erica EsrickDana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
Anthea L GreenwayDepartment Clinical Haematology, Royal Children's Hospital, Parkville and Department Haematology, Monash Health, Clayton, VIC, Australia.
Ibrahim M IdrisDepartment of Hematology, Aminu Kano Teaching Hospital/Bayero University Kano, Kano, Nigeria.
David-Zacharie IssomDepartment of Business Information Systems, School of Management, HES-SO University of Applied Sciences and Arts of Western Switzerland, Geneva, Switzerland.
Dipty JainDepartment of Paediatrics, Government Medical College, Nagpur, India.
Lori C JordanDepartment of Pediatrics, Division of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Zane S KaplanDepartment of Clinical Haematology, Monash Health and Monash University, Melbourne, VIC, Australia.
Allison A KingDepartments of Pediatrics and Internal Medicine, Divisions of Pediatric Hematology and Oncology and Hematology, Washington University School of Medicine, St Louis, MO, USA.
Michele Lloyd-PuryearEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Samuel A OppongDepartment of Obstetrics and Gynecology, University of Ghana Medical School, Accra, Ghana.
Akshay SharmaDepartment of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USA.
Lillian SungDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
Leon TshiloloInstitute of Biomedical Research/CEFA Monkole Hospital Centre and Official University of Mbuji-Mayi, Mbuji-Mayi, Democratic Republic of the Congo.
Diana J WilkieDepartment of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL, USA.
Kwaku Ohene-FrempongDivision of Hematology, Children's Hospital of Philadelphia, Pennsylvania, USA; Sickle Cell Foundation of Ghana, Kumasi, Ghana.
Funding
Sickle Pan African Research Consortium NigEria (SPARC-NEt)U01HL156942 · NHLBI · UNIVERSITY OF ABUJA · PI NNODU, OBIAGELI EUNICE · 2021 to 2025
$1.3MNHLBI NIH HHS U01 HL156942
Abstract
PubMed holds no abstract for this paper.
Indexed as
Anemia, Sickle CellHematologyGlobal HealthHumans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.